Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Cyclerion Therapeutics Inc CYCN

Healthcare Biotechnology
Cyclerion Therapeutics, Inc. is a clinical-stage biopharmaceutical company that focuses on developing treatments for serious diseases. The Company’s portfolio includes novel soluble guanylate cyclase (sGC) stimulators, namely praliciguat and olinciguat, as well as multiple research stage molecules. Praliciguat is a systemic sGC stimulator that is licensed to Akebia Therapeutics, Inc. for the... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:CYCN)

Cyclerion's sGC Stimulator Portfolio Generates Revenues to Enable Company Growth

GlobeNewswire December 17, 2024

Regina Graul, Ph.D., Promoted to Chief Executive Officer

GlobeNewswire August 7, 2024

Cyclerion Appoints Regina Graul, Ph.D., as President

GlobeNewswire December 4, 2023

Cyclerion Strengthens Board of Directors with Experienced Company Builder and Cutting-edge Innovator

GlobeNewswire November 30, 2023

Tisento Launches with $81 Million From Top-Tier Investor Syndicate and Promising Cyclerion Assets

GlobeNewswire July 31, 2023

Cyclerion Regains Compliance with Nasdaq Minimum Bid Price Requirement

GlobeNewswire June 1, 2023

Cyclerion Announces Reverse Stock Split

GlobeNewswire May 15, 2023

Cyclerion Announces Definitive Agreement for Zagociguat and CY3018

GlobeNewswire May 11, 2023

Cyclerion Announces Corporate Updates and Q1 2023 Financial Results

GlobeNewswire May 11, 2023
View More News ››

Opinion & Analysis (NDAQ:CYCN)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:CYCN)

Buy buddy buy because it's taking off this morning.

And furthermore you guys will be left behind,so there.
coolfooldumbguy - February 3, 2025

This stock is a good buy for me

At these low price per share levels and it is a good company with a big future ahead of it,so that it was time for me to be getting on...
coolfooldumbguy - January 31, 2025

Cyclerion Therapeutics, Inc. (CYCN): Navigating the Challeng

http://beyondspx.com/2024/08/01/cyclerion-therapeutics-inc-cycn-navigating-the-challenges-of-a-shifting-biotech-landscape/
MikeTester - August 1, 2024

5 STOCKS FOR YOUR INVESTMENT WATCHLIST!

5 STOCKS FOR YOUR INVESTMENT WATCHLIST!   CYCN COGT QIPT CHS POLY https://www.aviseanalytics.com/5-stocks-for-your...
AviseAnalytics - November 12, 2021

still holding this stock

it is starting to climb up,so glta shareholders.
coolfooldumbguy - December 16, 2019

still holding this stock CYCN on NASDAQ

it looks like a breakout today to the upside,so glta.
coolfooldumbguy - November 19, 2019
View more Bullboard ››

Mandalay Resources Corp.

Mandalay Resources Corp.

Mandalay Resources Corporation is a Canada-based natural resource company with producing assets in Australia (Costerfield ...
View More »